{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:43:43Z","timestamp":1791009823672,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,4]],"date-time":"2011-12-04T00:00:00Z","timestamp":1322956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1038\/nm.2575","type":"journal-article","created":{"date-parts":[[2011,12,4]],"date-time":"2011-12-04T20:28:39Z","timestamp":1323030519000},"page":"100-110","source":"Crossref","is-referenced-by-count":189,"title":["PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells"],"prefix":"10.1038","volume":"18","author":[{"given":"Yuan","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse Dahl Ejby","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Hedlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakiyo","family":"Sasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Galter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renhai","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Hosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihai","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,4]]},"reference":[{"key":"BFnm2575_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0065-230X(08)00004-3","volume":"100","author":"Y Cao","year":"2008","unstructured":"Cao, Y. Molecular mechanisms and therapeutic development of angiogenesis inhibitors. Adv. Cancer Res. 100, 113\u2013131 (2008).","journal-title":"Adv. Cancer Res."},{"key":"BFnm2575_CR2","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nature04478","volume":"438","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet, P. Angiogenesis in life, disease and medicine. Nature 438, 932\u2013936 (2005).","journal-title":"Nature"},{"key":"BFnm2575_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrd2115","volume":"6","author":"J Folkman","year":"2007","unstructured":"Folkman, J. Angiogenesis: an organizing principle for drug discovery? Nat. Rev. Drug Discov. 6, 273\u2013286 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnm2575_CR4","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1056\/NEJMra0706596","volume":"358","author":"RS Kerbel","year":"2008","unstructured":"Kerbel, R.S. Tumor angiogenesis. N. Engl. J. Med. 358, 2039\u20132049 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnm2575_CR5","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1172\/JCI200318549","volume":"112","author":"A Abramsson","year":"2003","unstructured":"Abramsson, A., Lindblom, P. & Betsholtz, C. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J. Clin. Invest. 112, 1142\u20131151 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnm2575_CR6","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature04483","volume":"438","author":"N Ferrara","year":"2005","unstructured":"Ferrara, N. & Kerbel, R.S. Angiogenesis as a therapeutic target. Nature 438, 967\u2013974 (2005).","journal-title":"Nature"},{"key":"BFnm2575_CR7","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/nrc1456","volume":"4","author":"CH Heldin","year":"2004","unstructured":"Heldin, C.H., Rubin, K., Pietras, K. & Ostman, A. High interstitial fluid pressure\u2014an obstacle in cancer therapy. Nat. Rev. Cancer 4, 806\u2013813 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm2575_CR8","first-page":"5297","volume":"53","author":"AD Soutter","year":"1993","unstructured":"Soutter, A.D., Nguyen, M., Watanabe, H. & Folkman, J. Basic fibroblast growth factor secreted by an animal tumor is detectable in urine. Cancer Res. 53, 5297\u20135299 (1993).","journal-title":"Cancer Res."},{"key":"BFnm2575_CR9","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/74725","volume":"6","author":"G Thurston","year":"2000","unstructured":"Thurston, G. et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6, 460\u2013463 (2000).","journal-title":"Nat. Med."},{"key":"BFnm2575_CR10","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0733-8619(18)31009-0","volume":"3","author":"B Westermark","year":"1985","unstructured":"Westermark, B., Nister, M. & Heldin, C.H. Growth factors and oncogenes in human malignant glioma. Neurol. Clin. 3, 785\u2013799 (1985).","journal-title":"Neurol. Clin."},{"key":"BFnm2575_CR11","doi-asserted-by":"publisher","first-page":"re1","DOI":"10.1126\/scisignal.262tr1","volume":"2","author":"Y Cao","year":"2009","unstructured":"Cao, Y. Positive and negative modulation of angiogenesis by VEGFR1 ligands. Sci. Signal. 2, re1 (2009).","journal-title":"Sci. Signal."},{"key":"BFnm2575_CR12","doi-asserted-by":"publisher","first-page":"18513","DOI":"10.1073\/pnas.0807967105","volume":"105","author":"Y Xue","year":"2008","unstructured":"Xue, Y. et al. Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndrome. Proc. Natl. Acad. Sci. USA 105, 18513\u201318518 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2575_CR13","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1172\/JCI32479","volume":"117","author":"LJ Nissen","year":"2007","unstructured":"Nissen, L.J. et al. Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. J. Clin. Invest. 117, 2766\u20132777 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnm2575_CR14","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrc2442","volume":"8","author":"G Bergers","year":"2008","unstructured":"Bergers, G. & Hanahan, D. Modes of resistance to anti-angiogenic therapy. Nat. Rev. Cancer 8, 592\u2013603 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm2575_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccr.2008.12.004","volume":"15","author":"Y Crawford","year":"2009","unstructured":"Crawford, Y. et al. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 15, 21\u201334 (2009).","journal-title":"Cancer Cell"},{"key":"BFnm2575_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.gde.2004.12.003","volume":"15","author":"NA Bhowmick","year":"2005","unstructured":"Bhowmick, N.A. & Moses, H.L. Tumor-stroma interactions. Curr. Opin. Genet. Dev. 15, 97\u2013101 (2005).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"BFnm2575_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nat. Rev. Cancer 6, 392\u2013401 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm2575_CR18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1535-6108(03)00089-8","volume":"3","author":"K Pietras","year":"2003","unstructured":"Pietras, K., Sjoblom, T., Rubin, K., Heldin, C.H. & Ostman, A. PDGF receptors as cancer drug targets. Cancer Cell 3, 439\u2013443 (2003).","journal-title":"Cancer Cell"},{"key":"BFnm2575_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccr.2005.08.002","volume":"8","author":"M De Palma","year":"2005","unstructured":"De Palma, M. et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8, 211\u2013226 (2005).","journal-title":"Cancer Cell"},{"key":"BFnm2575_CR20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.0954-6820.1987.tb09898.x","volume":"715","author":"B Westermark","year":"1987","unstructured":"Westermark, B. & Heldin, C.H. Structure and function of platelet-derived growth factor. Acta Med. Scand. Suppl. 715, 19\u201323 (1987).","journal-title":"Acta Med. Scand. Suppl."},{"key":"BFnm2575_CR21","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1096\/fj.02-0319com","volume":"16","author":"R Cao","year":"2002","unstructured":"Cao, R. et al. Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-\u03b1\u03b1 and -\u03b1\u03b2 receptors. FASEB J. 16, 1575\u20131583 (2002).","journal-title":"FASEB J."},{"key":"BFnm2575_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nm848","volume":"9","author":"R Cao","year":"2003","unstructured":"Cao, R. et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat. Med. 9, 604\u2013613 (2003).","journal-title":"Nat. Med."},{"key":"BFnm2575_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1096\/fj.08-113860","volume":"23","author":"J Zhang","year":"2009","unstructured":"Zhang, J. et al. Differential roles of PDGFR-\u03b1 and PDGFR-\u03b2 in angiogenesis and vessel stability. FASEB J. 23, 153\u2013163 (2009).","journal-title":"FASEB J."},{"key":"BFnm2575_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1126\/science.277.5323.242","volume":"277","author":"P Lindahl","year":"1997","unstructured":"Lindahl, P., Johansson, B.R., Leveen, P. & Betsholtz, C. Pericyte loss and microaneurysm formation in PDGF-B\u2013deficient mice. Science 277, 242\u2013245 (1997).","journal-title":"Science"},{"key":"BFnm2575_CR25","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1242\/dev.125.17.3313","volume":"125","author":"P Lindahl","year":"1998","unstructured":"Lindahl, P. et al. Paracrine PDGF-B\/PDGF-R\u03b2 signaling controls mesangial cell development in kidney glomeruli. Development 125, 3313\u20133322 (1998).","journal-title":"Development"},{"key":"BFnm2575_CR26","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1101\/gad.8.16.1888","volume":"8","author":"P Soriano","year":"1994","unstructured":"Soriano, P. Abnormal kidney development and hematological disorders in PDGF \u03b2-receptor mutant mice. Genes Dev. 8, 1888\u20131896 (1994).","journal-title":"Genes Dev."},{"key":"BFnm2575_CR27","first-page":"R1829","volume":"273","author":"KM Moritz","year":"1997","unstructured":"Moritz, K.M., Lim, G.B. & Wintour, E.M. Developmental regulation of erythropoietin and erythropoiesis. Am. J. Physiol. 273, R1829\u2013R1844 (1997).","journal-title":"Am. J. Physiol."},{"key":"BFnm2575_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2169\/internalmedicine.42.142","volume":"42","author":"R Sasaki","year":"2003","unstructured":"Sasaki, R. Pleiotropic functions of erythropoietin. Intern. Med. 42, 142\u2013149 (2003).","journal-title":"Intern. Med."},{"key":"BFnm2575_CR29","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1046\/j.1365-2362.2003.01245.x","volume":"33","author":"D Ribatti","year":"2003","unstructured":"Ribatti, D., Vacca, A., Roccaro, A.M., Crivellato, E. & Presta, M. Erythropoietin as an angiogenic factor. Eur. J. Clin. Invest. 33, 891\u2013896 (2003).","journal-title":"Eur. J. Clin. Invest."},{"key":"BFnm2575_CR30","first-page":"257","volume":"57","author":"M Baccarani","year":"1978","unstructured":"Baccarani, M. et al. The relevance of extramedullary hemopoiesis to the staging of chronic myeloid leukemia. Boll. Ist. Sieroter. Milan. 57, 257\u2013270 (1978).","journal-title":"Boll. Ist. Sieroter. Milan."},{"key":"BFnm2575_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00005792-197105000-00001","volume":"50","author":"JP Kushner","year":"1971","unstructured":"Kushner, J.P., Lee, G.R., Wintrobe, M.M. & Cartwright, G.E. Idiopathic refractory sideroblastic anemia: clinical and laboratory investigation of 17 patients and review of the literature. Medicine (Baltimore) 50, 139\u2013159 (1971).","journal-title":"Medicine (Baltimore)"},{"key":"BFnm2575_CR32","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1158\/1078-0432.CCR-06-3061","volume":"13","author":"P Saintigny","year":"2007","unstructured":"Saintigny, P. et al. Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer. Clin. Cancer Res. 13, 4825\u20134831 (2007).","journal-title":"Clin. Cancer Res."},{"key":"BFnm2575_CR33","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.exphem.2009.01.004","volume":"37","author":"LE Lenox","year":"2009","unstructured":"Lenox, L.E., Shi, L., Hegde, S. & Paulson, R.F. Extramedullary erythropoiesis in the adult liver requires BMP-4\/Smad5-dependent signaling. Exp. Hematol. 37, 549\u2013558 (2009).","journal-title":"Exp. Hematol."},{"key":"BFnm2575_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/jnci\/djk031","volume":"99","author":"T Nakayama","year":"2007","unstructured":"Nakayama, T., Mutsuga, N. & Tosato, G. Effect of fibroblast growth factor 2 on stromal cell-derived factor 1 production by bone marrow stromal cells and hematopoiesis. J. Natl. Cancer Inst. 99, 223\u2013235 (2007).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFnm2575_CR35","doi-asserted-by":"publisher","first-page":"6988","DOI":"10.1074\/jbc.M707514200","volume":"283","author":"S Kiryu-Seo","year":"2008","unstructured":"Kiryu-Seo, S. et al. Neuronal injury-inducible gene is synergistically regulated by ATF3, c-Jun, and STAT3 through the interaction with Sp1 in damaged neurons. J. Biol. Chem. 283, 6988\u20136996 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFnm2575_CR36","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1359\/jbmr.080409","volume":"23","author":"A Tokunaga","year":"2008","unstructured":"Tokunaga, A. et al. PDGF receptor \u03b2 is a potent regulator of mesenchymal stromal cell function. J. Bone Miner. Res. 23, 1519\u20131528 (2008).","journal-title":"J. Bone Miner. Res."},{"key":"BFnm2575_CR37","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/nm723","volume":"8","author":"C Grimm","year":"2002","unstructured":"Grimm, C. et al. HIF-1\u2013induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat. Med. 8, 718\u2013724 (2002).","journal-title":"Nat. Med."},{"key":"BFnm2575_CR38","doi-asserted-by":"publisher","first-page":"e549","DOI":"10.1371\/journal.pone.0000549","volume":"2","author":"ME Hardee","year":"2007","unstructured":"Hardee, M.E. et al. Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression. PLoS ONE 2, e549 (2007).","journal-title":"PLoS ONE"},{"key":"BFnm2575_CR39","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1161\/CIRCRESAHA.108.182287","volume":"103","author":"P Korpisalo","year":"2008","unstructured":"Korpisalo, P. et al. Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogenic vessels. Circ. Res. 103, 1092\u20131099 (2008).","journal-title":"Circ. Res."},{"key":"BFnm2575_CR40","doi-asserted-by":"publisher","first-page":"19976","DOI":"10.1074\/jbc.M110.102467","volume":"285","author":"S Wang","year":"2010","unstructured":"Wang, S., Dale, G.L., Song, P., Viollet, B. & Zou, M.H. AMPK\u03b11 deletion shortens erythrocyte life span in mice: role of oxidative stress. J. Biol. Chem. 285, 19976\u201319985 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnm2575_CR41","doi-asserted-by":"publisher","first-page":"6072","DOI":"10.1182\/blood-2010-04-281840","volume":"116","author":"S Millot","year":"2010","unstructured":"Millot, S. et al. Erythropoietin stimulates spleen BMP4-dependent stress erythropoiesis and partially corrects anemia in a mouse model of generalized inflammation. Blood 116, 6072\u20136081 (2010).","journal-title":"Blood"},{"key":"BFnm2575_CR42","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1172\/JCI41291","volume":"120","author":"OF Harandi","year":"2010","unstructured":"Harandi, O.F., Hedge, S., Wu, D.C., McKeone, D. & Paulson, R.F. Murine erythroid short-term radioprotection requires a BMP4-dependent, self-renewing population of stress erythroid progenitors. J. Clin. Invest. 120, 4507\u20134519 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnm2575_CR43","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/sj.onc.1209781","volume":"26","author":"K Ameri","year":"2007","unstructured":"Ameri, K. et al. Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signalling pathway. Oncogene 26, 284\u2013289 (2007).","journal-title":"Oncogene"},{"key":"BFnm2575_CR44","first-page":"526","volume":"118","author":"J Chen","year":"2008","unstructured":"Chen, J., Connor, K.M., Aderman, C.M. & Smith, L.E. Erythropoietin deficiency decreases vascular stability in mice. J. Clin. Invest. 118, 526\u2013533 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnm2575_CR45","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1182\/blood-2003-04-1284","volume":"103","author":"FH Bahlmann","year":"2004","unstructured":"Bahlmann, F.H. et al. Erythropoietin regulates endothelial progenitor cells. Blood 103, 921\u2013926 (2004).","journal-title":"Blood"},{"key":"BFnm2575_CR46","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/BF02187191","volume":"137","author":"M Kurimoto","year":"1995","unstructured":"Kurimoto, M., Nishijima, M., Hirashima, Y., Endo, S. & Takaku, A. Plasma platelet-derived growth factor-B chain is elevated in patients with extensively large brain tumour. Acta Neurochir. (Wien) 137, 182\u2013187 (1995).","journal-title":"Acta Neurochir. (Wien)"},{"key":"BFnm2575_CR47","first-page":"4149","volume":"51","author":"K Leitzel","year":"1991","unstructured":"Leitzel, K. et al. Elevated plasma platelet-derived growth factor B-chain levels in cancer patients. Cancer Res. 51, 4149\u20134154 (1991).","journal-title":"Cancer Res."},{"key":"BFnm2575_CR48","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/BF01395704","volume":"26","author":"T Yamaguchi","year":"1996","unstructured":"Yamaguchi, T. et al. Renal cell carcinoma in a patient with Beckwith-Wiedemann syndrome. Pediatr. Radiol. 26, 312\u2013314 (1996).","journal-title":"Pediatr. Radiol."},{"key":"BFnm2575_CR49","doi-asserted-by":"publisher","first-page":"10185","DOI":"10.1073\/pnas.0803194105","volume":"105","author":"F Kuhnert","year":"2008","unstructured":"Kuhnert, F. et al. Soluble receptor-mediated selective inhibition of VEGFR and PDGFR-\u03b2 signaling during physiologic and tumor angiogenesis. Proc. Natl. Acad. Sci. USA 105, 10185\u201310190 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2575_CR50","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.1158\/0008-5472.CAN-09-4245","volume":"70","author":"MH Nisancioglu","year":"2010","unstructured":"Nisancioglu, M.H., Betsholtz, C. & Genove, G. The absence of pericytes does not increase the sensitivity of tumor vasculature to vascular endothelial growth factor-A blockade. Cancer Res. 70, 5109\u20135115 (2010).","journal-title":"Cancer Res."},{"key":"BFnm2575_CR51","first-page":"970","volume":"1","author":"KM Kirschner","year":"2003","unstructured":"Kirschner, K.M. & Baltensperger, K. Erythropoietin promotes resistance against the Abl tyrosine kinase inhibitor imatinib (STI571) in K562 human leukemia cells. Mol. Cancer Res. 1, 970\u2013980 (2003).","journal-title":"Mol. Cancer Res."},{"key":"BFnm2575_CR52","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cmet.2008.11.009","volume":"9","author":"Y Xue","year":"2009","unstructured":"Xue, Y. et al. Hypoxia-independent angiogenesis in adipose tissues during cold acclimation. Cell Metab. 9, 99\u2013109 (2009).","journal-title":"Cell Metab."},{"key":"BFnm2575_CR53","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ccr.2004.08.034","volume":"6","author":"R Cao","year":"2004","unstructured":"Cao, R. et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6, 333\u2013345 (2004).","journal-title":"Cancer Cell"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.2575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2575","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T07:46:15Z","timestamp":1713167175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.2575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,4]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["BFnm2575"],"URL":"https:\/\/doi.org\/10.1038\/nm.2575","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,4]]}}}